LabCorp expands in the Midwest through South Bend acquisition

LabCorp will operate the foundation’s former clinical lab in South Bend as well as six additional South Bend Medical Foundation patient service locations and four LabCorp sites within local Walgreens stores. (LabCorp)

LabCorp has acquired the diagnostic lab testing business of Indiana’s South Bend Medical Foundation (SBMF), expanding its clinical offerings to the surrounding area including parts of Michigan, Ohio and Illinois.

Additionally, LabCorp and the nonprofit foundation have agreed to work together to provide pathology services to the region, including through LabCorp’s Dianon Pathology and Integrated Oncology labs.

“This transaction will allow SBMF to focus on our core business of pathology and blood banking services,” the foundation’s president, Joyce Simpson, said in a statement.


Lipid-based Formulations for Early Stage Clinical Trials

Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.

“I am confident that our customers and patients will benefit from the enhanced clinical laboratory services that LabCorp can offer, and I look forward to working closely with LabCorp in a new pathology partnership as SBMF expands its professional services,” Simpson said.

RELATED: Mount Sinai pairs with LabCorp and Philips to build out its AI-driven pathology center

Going forward, LabCorp will operate the foundation’s former clinical laboratory in South Bend as part of a larger network of patient service centers. That includes six additional former SBMF locations and four LabCorp sites opened within Walgreens stores in southwestern Michigan.

“This year, LabCorp is celebrating five decades of providing innovative, customer-focused clinical laboratory services as part of our mission to improve health and improve lives,” said Amy Rhine-Pallas, senior vice president of LabCorp Diagnostic’s north central division. “I am proud and excited that we will begin our next 50 years by expanding our presence in South Bend and the surrounding markets and establishing a collaboration with the highly regarded pathologists and staff at SBMF.”

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Invitae aims to expand its genetic counseling reach through the $50 million acquisition of Clear Genetics, developers of digital chatbot software.